The Wnt signaling pathway and its role in tumor development
Top Cited Papers
- 18 April 2003
- journal article
- review article
- Published by Springer Nature in Zeitschrift für Krebsforschung und Klinische Onkologie
- Vol. 129 (4), 199-221
- https://doi.org/10.1007/s00432-003-0431-0
Abstract
Cancer development depends on the aberrant activation of signal transduction pathways that control cell growth and survival and play important roles in normal embryonic development. This review will focus on one of the most powerful pathways, the canonical Wnt signal transduction cascade, which has been originally described in vertebrate and non-vertebrate embryogenesis and subsequently associated with the development of a multitude of different tumor types, mainly of gastrointestinal origin. In recent years, a variety of novel interacting components and functions have been identified in the Wnt pathway revealing not only the complexity of Wnt signaling but also its potency. Here we will concentrate on the role of the Wnt pathway in cancer development with emphasis placed on the molecular defects known to promote neoplastic transformation in humans and in animal models.Keywords
This publication has 233 references indexed in Scilit:
- Cytoplasmic and/or nuclear accumulation of the β‐catenin protein is a frequent event in human osteosarcomaInternational Journal of Cancer, 2002
- APC/CTNNB1 (β‐catenin) pathway alterations in human prostate cancersGenes, Chromosomes and Cancer, 2002
- Wnt Signaling and Heterotrimeric G-Proteins: Strange Bedfellows or a Classic Romance?Biochemical and Biophysical Research Communications, 2001
- Dickkopf1 Is Required for Embryonic Head Induction and Limb Morphogenesis in the MouseDevelopmental Cell, 2001
- Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating β-catenin/TCF signallingNature Genetics, 2000
- The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous PolyposisNew England Journal of Medicine, 2000
- GSK-3β-dependent phosphorylation of adenomatous polyposis coli gene product can be modulated by β-catenin and protein phosphatase 2A complexed with AxinOncogene, 2000
- Intestinal polyposis in mice with a dominant stable mutation of the beta -catenin geneThe EMBO Journal, 1999
- Downregulation of β-catenin by human Axin and its association with the APC tumor suppressor, β-catenin and GSK3βCurrent Biology, 1998
- Hypermethylation of the APC (adenomatous Polyposis Coli) gene promoter region in human colorectal carcinomaInternational Journal of Cancer, 1997